ADVM
Adverum Biotechnologies Inc
$11.34
Earnings Summary
Revenue | $0Mn |
Net Profits | $-23.71Mn |
Net Profit Margins | -Inf% |
Highlights
Adverum Biotechnologies Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Adverum Biotechnologies Inc has generated NaN% jump in its revenue since last 3-months.
Adverum Biotechnologies Inc’s net profit jumped 27.56% since last year same period to $-23.71Mn in the Q4 2023. On a quarterly growth basis, Adverum Biotechnologies Inc has generated 27.89% jump in its net profits since last 3-months.
Adverum Biotechnologies Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Adverum Biotechnologies Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Adverum Biotechnologies Inc post its latest quarter earnings
EPS Estimate Current Quarter | -1.41 |
EPS Estimate Current Year | -1.41 |
Highlights
Adverum Biotechnologies Inc’s earning per share (EPS) estimates for the current quarter stand at -1.41 - a 58.16% jump from last quarter’s estimates.
Adverum Biotechnologies Inc’s earning per share (EPS) estimates for the current year stand at -1.41.
Key Ratios
Key ratios of the Adverum Biotechnologies Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -2.3 |
Highlights
Adverum Biotechnologies Inc’s earning per share (EPS) fell -596.97% since last year same period to -2.3 in the Q4 2023. This indicates that the Adverum Biotechnologies Inc has generated -596.97% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-09 | -0.32 | -0.33 | -3.13% |
2023-08-10 | -0.33 | -0.31 | 6.06% |
2024-03-18 | -3.37 | -2.3 | 31.75% |
2023-05-11 | -0.32 | -0.29 | 9.38% |
₹0 US Stocks a/c Opening Fee